Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 9/20 | 0.58 |
| ▸ | NPY1R | P25929 | 5/20 | 0.58 |
| ▸ | NPY2R | P49146 | 4/20 | 0.58 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.58 |
| ▸ | VIPR2 | P41587 | 6/20 | 0.57 |
| ▸ | TFPI | P10646 | 1/20 | 0.57 |
| ▸ | VIPR1 | P32241 | 4/20 | 0.57 |
| ▸ | KDM1A | O60341 | 1/20 | 0.52 |
| ▸ | MAOB | P27338 | 1/20 | 0.52 |
| ▸ | KDM5A | P29375 | 1/20 | 0.52 |
| ▸ | KDM1B | Q8NB78 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29611523 | 0.95 | NPY4R (0.60) | NPY4RNPY1RNPY2RNPY5RVIPR2 | |
| SCHEMBL29512422 | 0.94 | NPY4R (0.61) | NPY4RNPY1RNPY2RNPY5RVIPR2 | |
| SCHEMBL29611531 | 0.94 | NPY4R (0.64) | NPY4RNPY1RNPY2RNPY5RVIPR2 | |
| Thymopentin SCHEMBL29512388 | 0.93 | NPY4R (0.62) | NPY4RNPY1RNPY2RNPY5RVIPR2 | |
| Thymopentin SCHEMBL7498758 | 0.93 | NPY4R (0.62) | NPY4RNPY1RNPY2RNPY5RVIPR2 | |
| Thymopentin SCHEMBL44001 | 0.93 | NPY4R (0.62) | NPY4RNPY1RNPY2RNPY5RVIPR2 | |
| Thymopentin SCHEMBL29512423 | 0.93 | NPY4R (0.62) | NPY4RNPY1RNPY2RNPY5RVIPR2 | |
| Thymopentin SCHEMBL989519 | 0.93 | NPY4R (0.62) | NPY4RNPY1RNPY2RNPY5RVIPR2 | |
| Thymopentin SCHEMBL29512397 | 0.93 | NPY4R (0.62) | NPY4RNPY1RNPY2RNPY5RVIPR2 | |
| SCHEMBL30331711 | 0.93 | NPY4R (0.62) | NPY4RNPY1RNPY2RNPY5RVIPR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12419824-B2 | Compounds useful for the treatment and/or care of the skin, hair, nails and/or mucous membranes | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2025-09-23 | — | — | US | disclosed |
| US-20220183950-A1 | COMPOUNDS USEFUL FOR THE TREATMENT AND/OR CARE OF THE SKIN, HAIR, NAILS AND/OR MUCOUS MEMBRANES | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2022-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220183950-A1 | COMPOUNDS USEFUL FOR THE TREATMENT AND/OR CARE OF THE SKIN, HAIR, NAILS AND/OR MUCOUS MEMBRANES | TYR, TELO2, MTX2 | NPY4R 124/4885NPY1R 65/4885NPY2R 52/4885 |
| US-12419824-B2 | Compounds useful for the treatment and/or care of the skin, hair, nails and/or mucous membranes | TYR, TELO2, MTX2 | NPY4R 124/4885NPY1R 65/4885NPY2R 52/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.